abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 82,667 shares, a decline of 39.7% from the August 15th total of 137,144 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average daily trading volume, of 219,445 shares, the short-interest ratio is currently 0.4 days.
Institutional Investors Weigh In On abrdn Healthcare Investors
Hedge funds and other institutional investors have recently made changes to their positions in the business. Bollard Group LLC acquired a new stake in shares of abrdn Healthcare Investors in the first quarter worth approximately $25,000. Global Retirement Partners LLC acquired a new position in abrdn Healthcare Investors during the fourth quarter worth approximately $106,000. Integrated Wealth Concepts LLC acquired a new position in abrdn Healthcare Investors during the second quarter worth approximately $149,000. Ameritas Advisory Services LLC purchased a new position in abrdn Healthcare Investors during the second quarter worth approximately $149,000. Finally, Fifth Third Bancorp purchased a new position in abrdn Healthcare Investors during the first quarter worth approximately $123,000. Hedge funds and other institutional investors own 32.60% of the company’s stock.
abrdn Healthcare Investors Stock Up 0.3%
NYSE HQH traded up $0.07 during mid-day trading on Wednesday, reaching $21.46. 97,980 shares of the stock were exchanged, compared to its average volume of 187,368. abrdn Healthcare Investors has a 1-year low of $16.43 and a 1-year high of $24.85. The business’s fifty day simple moving average is $22.39 and its 200 day simple moving average is $20.46.
abrdn Healthcare Investors Announces Dividend
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE: HQH) is a non-diversified, closed-end investment company focused on the healthcare and life sciences sectors. The fund seeks long-term capital appreciation by investing in a portfolio of public and private companies involved in areas such as biotechnology, pharmaceuticals, medical devices, healthcare services and other related industries.
The fund invests primarily in equity securities, including common stocks and other securities of healthcare companies at various stages of development.
Featured Articles
- Five stocks we like better than abrdn Healthcare Investors
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
